Compare Interactive Brokers Group Inc. Class A Common Stock (IBKR) vs Johnson & Johnson (JNJ) Price & Performance

Interactive Brokers Group Inc. Class A Common StockTrade

Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Interactive Brokers Group Inc. Class A Common Stock vs Johnson & Johnson — how do they compare? Interactive Brokers Group Inc. Class A Common Stock trades at $87.63 (market cap $39.18B), while Johnson & Johnson trades at $259.14 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 15.8× Interactive Brokers Group Inc. Class A Common Stock's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Interactive Brokers Group Inc. Class A Common Stock for 0 Days and Johnson & Johnson for 129 Days on average.

	IBKR	JNJ
Market Cap	$39.18B	$618.09B
Volume	2,996,599	6,050,983
Sector	Financials	Health
52-Week High	$98.19	$278.43
52-Week Low	$61.05	$186.00
Typical Hold Time	0 Days	129 Days
Enterprise Value	$31.48B	$646.37B
Dividend Yield	0.4%	2.09%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Interactive Brokers Group Inc. Class A Common Stock

No Aura AI signal available yet.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $258.45, up 1.44% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and robust cash flow. Analyst consensus is bullish with a $286.53 price target, though technical indicators show resistance near $260. Recent news highlights pipeline strength including Icotyde's potential $4.5B peak sales.

JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and competitive pressures. The stock presents value near current levels with 10.7% upside to consensus target, though technical weakness suggests potential near-term consolidation. Long-term growth drivers include oncology portfolio and Ottava surgical system development.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IBKR

100% Buy0% Sell

Avg holding period · 0 Days

JNJ

96% Buy4% Sell

Avg holding period · 129 Days

Top news

Latest headlines on both assets

IBKR

Interactive Brokers seen as speculative sell amid high valuations and slowing revenue growthSeeking Alpha · 5 hours agoBearish View details →

JNJ

Johnson & Johnson Q3 earnings expected with 5% EPS drop but 5.8% revenue growthGordon Thompson · 4 hours agoNeutral Four Dividend Kings remain strong but PepsiCo's dividend payout is riskier than others.24/7 Wall Street · 6 hours agoNeutral New Phase 3 data show ICOTYDE provides lasting skin clearance in moderate-to-severe plaque psoriasis over two years.PRNewsWire · 8 hours agoBullish View details →

About Interactive Brokers Group Inc. Class A Common Stock

Interactive Brokers operates an electronic brokerage platform for trading stocks, options, futures, currencies, and other assets. It also provides clearing and custody services.

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.